Literature DB >> 25521667

Coronary In-Stent Restenosis: Assessment with Corrected Coronary Opacification Difference across Coronary Stents Measured with CT Angiography.

Yang Gao1, Bin Lu, Zhi Hui Hou, Fang Fang Yu, Wei Hua Yin, Zhi Qiang Wang, Yong Jian Wu, Chao Wei Mu, Felix G Meinel, Andrew D McQuiston, U Joseph Schoepf.   

Abstract

PURPOSE: To determine whether changes in coronary opacification normalized to the aorta (corrected coronary opacification [CCO]) across stents can help identify in-stent restenosis (ISR) severity with use of invasive coronary angiography as the standard of reference.
MATERIALS AND METHODS: This study was approved by the institutional review board, and the requirement to obtain informed consent was waived. The authors retrospectively analyzed 106 patients (88 men, 18 women; mean age, 59.6 years ± 10.4; age range, 36-84 years) who had previously undergone stent implantation within 3 months of coronary computed tomographic (CT) angiography. Attenuation values in the coronary lumen were measured proximal and distal to the stents and normalized to the descending aorta. The CCO difference across the stent was compared with the severity of ISR. One-way analysis of variance least significant difference was used for comparison.
RESULTS: A total of 141 stents were assessed. Seventy-six stents were normally patent, 18 had ISR of less than 50%, 28 had ISR of 50%-99%, and 19 were fully occluded. The median CCO differences in the four groups were 0.078, 0.163, 0.346, and 0.606, respectively. There was no significant difference between stents with an ISR of at least 50% and those with total occlusion (P = .056), although the other groups had significant differences at pairwise comparison (P < .01 for all). For stents smaller than 3 mm in diameter, the median CCO differences in the four groups were 0.086, 0.136, 0.390, and 0.471, respectively. The CCO differences across normal stents and stents with ISR of less than 50% were significantly less than those across stents with an ISR of at least 50% and those with total occlusion (P < .01 for all). There were no significant differences between stents with no ISR and those with an ISR of less than 50% (P = .821) and between stents with an ISR of at least 50% and those with an ISR of 100% (P = .836).
CONCLUSION: The CCO difference across coronary stents is related to ISR severity in obstructive ISR in stents smaller than 3 mm in diameter. © RSNA, 2014.

Entities:  

Mesh:

Year:  2014        PMID: 25521667     DOI: 10.1148/radiol.14140820

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  6 in total

1.  Stent evaluation by coronary computed tomography angiography: a comparison between Iopamidol-370 and Ioversol-320 hypo-osmolar iodine concentration contrasts.

Authors:  Annelisa Moura Garcia; Antonildes N Assunção-Jr; Roberto Nery Dantas-Jr; Jose Rodrigues Parga; Fernando Ganem
Journal:  Br J Radiol       Date:  2020-08-20       Impact factor: 3.039

2.  Salvage versus primary holmium laser enucleation of the prostate: trends, outcomes and safety analysis.

Authors:  Adri M Durant; Jonathan Moore; Sandeep Voleti; Sarah Wu; Lanyu Mi; Gopal Narang; Scott Cheney; Mitchell Humphreys
Journal:  World J Urol       Date:  2022-07-22       Impact factor: 3.661

3.  Evaluation of CT Angiography Image Quality Acquired with Single-Energy Metal Artifact Reduction (SEMAR) Algorithm in Patients After Complex Endovascular Aortic Repair.

Authors:  M A A D Ragusi; R W van der Meer; R M S Joemai; J van Schaik; C S P van Rijswijk
Journal:  Cardiovasc Intervent Radiol       Date:  2017-10-30       Impact factor: 2.740

4.  Diagnostic value of intraluminal stent enhancement in estimating coronary in-stent restenosis.

Authors:  Mehdi Karami Nogourani; Maryam Moradi; Amirreza Sajjadieh Khajouei; Maryam Farghadani; Atefeh Eshaghian
Journal:  J Clin Imaging Sci       Date:  2020-03-31

Review 5.  Diabetes and restenosis.

Authors:  Scott Wilson; Pasquale Mone; Urna Kansakar; Stanislovas S Jankauskas; Kwame Donkor; Ayobami Adebayo; Fahimeh Varzideh; Michael Eacobacci; Jessica Gambardella; Angela Lombardi; Gaetano Santulli
Journal:  Cardiovasc Diabetol       Date:  2022-02-14       Impact factor: 9.951

6.  Ex vivo assessment and in vivo validation of non-invasive stent monitoring techniques based on microwave spectrometry.

Authors:  Carolina Gálvez-Montón; Gianluca Arauz-Garofalo; Oriol Rodriguez-Leor; Carolina Soler-Botija; Susana Amorós García de Valdecasas; Flavio David Gerez-Britos; Antoni Bayes-Genis; Juan Manuel O'Callaghan; Ferran Macià; Javier Tejada
Journal:  Sci Rep       Date:  2018-10-04       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.